For: | Diwakarla C, Hannan K, Hein N, Yip D. Advanced pancreatic ductal adenocarcinoma - Complexities of treatment and emerging therapeutic options. World J Gastroenterol 2017; 23(13): 2276-2285 [PMID: 28428707 DOI: 10.3748/wjg.v23.i13.2276] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v23/i13/2276.htm |
Number | Citing Articles |
1 |
Btissame El Hassouni, Dzjemma Sarkisjan, J. Chris Vos, Elisa Giovannetti, Godefridus J. Peters. Targeting the Ribosome Biogenesis Key Molecule Fibrillarin to Avoid Chemoresistance. Current Medicinal Chemistry 2019; 26(33): 6020 doi: 10.2174/0929867326666181203133332
|
2 |
Hu Ren, Chao‑Rui Wu, Saderbieke Aimaiti, Cheng‑Feng Wang. Development and validation of a novel nomogram for predicting the prognosis of patients with resected pancreatic adenocarcinoma. Oncology Letters 2020; doi: 10.3892/ol.2020.11495
|
3 |
Jiang Zhong, XingShu Liao, Shuang Peng, Junyi Cao, Yue Liu, Chunyang Liu, Ju Qiu, Xiaoyan Guan, Yang Zhang, Xiaozhu Liu, Shengxian Peng. A Visualized Dynamic Prediction Model for Overall Survival in Elderly Patients With Pancreatic Cancer for Smart Medical Services. Frontiers in Public Health 2022; 10 doi: 10.3389/fpubh.2022.885624
|
4 |
Nahla E. El‐Ashmawy, Ghada M. Al‐Ashmawy, Sara M. Hamouda. Long non‐coding RNA FAM83H‐AS1 as an emerging marker for diagnosis, prognosis and therapeutic targeting of cancer. Cell Biochemistry and Function 2021; 39(3): 350 doi: 10.1002/cbf.3601
|
5 |
Cigdem Gungormez. Identification of hub genes and key pathways targeted by miRNAs in pancreatic ductal adenocarcinoma: MAPK3/8/9 and TGFBR1/2. Human Gene 2024; 39: 201267 doi: 10.1016/j.humgen.2024.201267
|
6 |
Roberta Peruzzo, Andrea Mattarei, Matteo Romio, Cristina Paradisi, Mario Zoratti, Ildikò Szabò, Luigi Leanza. Regulation of Proliferation by a Mitochondrial Potassium Channel in Pancreatic Ductal Adenocarcinoma Cells. Frontiers in Oncology 2017; 7 doi: 10.3389/fonc.2017.00239
|
7 |
Herve Tiriac, Juan Carlos Bucobo, Demetrios Tzimas, Suman Grewel, Joseph F. Lacomb, Leahana M. Rowehl, Satish Nagula, Maoxin Wu, Joseph Kim, Aaron Sasson, Shivakumar Vignesh, Laura Martello, Maria Munoz-Sagastibelza, Jonathan Somma, David A. Tuveson, Ellen Li, Jonathan M. Buscaglia. Successful creation of pancreatic cancer organoids by means of EUS-guided fine-needle biopsy sampling for personalized cancer treatment. Gastrointestinal Endoscopy 2018; 87(6): 1474 doi: 10.1016/j.gie.2017.12.032
|
8 |
Zengyu Feng, Minmin Shi, Kexian Li, Yang Ma, Lingxi Jiang, Hao Chen, Chenghong Peng. Development and validation of a cancer stem cell-related signature for prognostic prediction in pancreatic ductal adenocarcinoma. Journal of Translational Medicine 2020; 18(1) doi: 10.1186/s12967-020-02527-1
|
9 |
Ashley F. Tsue, Evan E. Kania, Diana Q. Lei, Rose Fields, Christopher D. McGann, Daphnée M. Marciniak, Elliot A. Hershberg, Xinxian Deng, Maryanne Kihiu, Shao-En Ong, Christine M. Disteche, Sita Kugel, Brian J. Beliveau, Devin K. Schweppe, David M. Shechner. Multiomic characterization of RNA microenvironments by oligonucleotide-mediated proximity-interactome mapping. Nature Methods 2024; 21(11): 2058 doi: 10.1038/s41592-024-02457-6
|
10 |
Ning Pu, Yang Lv, Guochao Zhao, Wanling Lee, Abulimiti Nuerxiati, Dansong Wang, Xuefeng Xu, Tiantao Kuang, Wenchuan Wu, Wenhui Lou. Survival Prediction in Pancreatic Cancer Patients with No Distant Metastasis: A Large-Scale Population-Based Estimate. Future Oncology 2018; 14(2): 165 doi: 10.2217/fon-2017-0380
|
11 |
Md Asad Ullah, Bishajit Sarkar, Fayza Akter. Prediction of biomarker signatures and therapeutic agents from blood sample against Pancreatic Ductal Adenocarcinoma (PDAC): A network-based study. Informatics in Medicine Unlocked 2020; 19: 100346 doi: 10.1016/j.imu.2020.100346
|
12 |
Hong-Yeoul Ryu. SUMO pathway is required for ribosome biogenesis. BMB Reports 2022; 55(11): 535 doi: 10.5483/BMBRep.2022.55.11.130
|